10:29 a.m. Sept. 25, 2024: A previous version of this article misstated the classification of Adderall as a controlled substance. It is Schedule II, not Schedule III. For the first time in decades, ...

Washington — President Trump signed an executive order on Thursday to reschedule marijuana to a lower drug classification, one of the most significant changes to drug policy in decades. "Today I'm ...

The order is expected to reclassify marijuana from a Schedule I drug to a Schedule III drug. According to the Drug Enforcement Administration, Schedule I applies to substances with “no currently ...

President Trump signed an executive order on Thursday to reschedule marijuana to a lower drug classification, one of the most significant changes to drug policy in decades. “Today I’m pleased to ...

For more than 50 years, marijuana has been classified as a Schedule I drug, alongside drugs considered to have no accepted medical use, thanks to then-President Richard Nixon’s so-called War on Drugs.

YORK, Pa. — President Donald Trump signed an executive order Thursday that could reclassify marijuana as a less dangerous drug and open new avenues for medical research. The switch would move ...

The Drug Enforcement Administration is reportedly planning to reclassify marijuana so it is no longer categorized as one of the most dangerous and addictive drugs—a decision that would fall short of ...

A view of a marijuana plant in San Anselmo, California, on August 11, 2025. Reporter President Donald Trump has ordered federal restrictions on marijuana to be loosened. The executive order, signed ...

The Department of Justice moved to reclassify marijuana as a less dangerous drug Thursday, in a historic move that could pave the way for a major expansion of medical use, though the proposal still ...

"Today I'm pleased to announce that I will be signing an executive order to reschedule marijuana from a Schedule I to a Schedule III controlled substance, with legitimate medical uses," Mr. Trump said ...

For the first time in decades, there are positive signs that the overdose crisis is finally slowing. What’s behind this progress is subject to debate, but one of its likely drivers is policy reform.